The correlation between serum total bile acid and adverse perinatal outcomes in pregnant women with intrahepatic cholestasis of pregnancy (ICP) and non-ICP hypercholanemia of pregnancy

References

• Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019;393(10174):1–11. doi: 10.1016/S0140-6736(18)31877-4.
   PubMed Web of Science ®Google Scholar
• Geenes V, Chappell LC, Seed PT, et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology. 2014;59(4):1482–1491. doi: 10.1002/hep.26617.
   PubMed Web of Science ®Google Scholar
• Fu C, Xu Y. Value of serum glycocholic acid and total bile acids in predicting maternal and perinatal outcomes in intrahepatic cholestasis of pregnancy. J Healthc Eng. 2021;2021:3911998. -. doi: 10.1155/2021/3911998.
   PubMed Web of Science ®Google Scholar
• Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol. 2018;231:180–187. doi: 10.1016/j.ejogrb.2018.10.041.
   PubMed Web of Science ®Google Scholar
• Qi H, Liu X. [Review and further explain the new "guidelines for diagnosis and treatment of intrahepatic cholestasis of pregnancy (2015)"]. Zhonghua Fu Chan Ke Za Zhi. 2015;50(7):486–488.
   PubMedGoogle Scholar
• Tran TT, Ahn J, Reau NS. ACG clinical guideline: liver disease and pregnancy. Am J Gastroenterol. 2016;111(2):176–194; quiz 196. doi: 10.1038/ajg.2015.430.
   PubMed Web of Science ®Google Scholar
• Hu Y, Ding YL, Yu L. The impact of intrahepatic cholestasis of pregnancy with hepatitis B virus infection on perinatal outcomes. Ther Clin Risk Manag. 2014;10:381–385. doi: 10.2147/TCRM.S61530.
   PubMed Web of Science ®Google Scholar
• Wu K, Wang H, Li S, et al. Maternal hepatitis B infection status and adverse pregnancy outcomes: a retrospective cohort analysis. Arch Gynecol Obstet. 2020;302(3):595–602. doi: 10.1007/s00404-020-05630-2.
   PubMed Web of Science ®Google Scholar
• Wu K, Yin B, Li S, et al. Prevalence, risk factors and adverse perinatal outcomes for Chinese women with intrahepatic cholestasis of pregnancy: a large cross-sectional retrospective study. Ann Med. 2022;54(1):2966–2974. doi: 10.1080/07853890.2022.2136400.
   PubMed Web of Science ®Google Scholar
• Jiang R, Wang T, Yao Y, et al. Hepatitis B infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Medicine . 2020;99(31):e21416.). doi: 10.1097/MD.0000000000021416.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wei H, Zhu YX. Adverse pregnancy outcomes and mother-to-child transmission in patients with hepatitis B virus infection and intrahepatic cholestasis of pregnancy. Ginekol Pol. 2022;93(5):396–404.
   PubMed Web of Science ®Google Scholar
• Martinefski M, Contin M, Lucangioli S, et al. In search of an accurate evaluation of intrahepatic cholestasis of pregnancy. Scientifica . 2012;2012:496489. doi: 10.6064/2012/496489.
   PubMedGoogle Scholar
• Castaño G, Lucangioli S, Sookoian S, et al. Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy. Clin Sci . 2006;110(4):459–465. doi: 10.1042/CS20050302.
   Web of Science ®Google Scholar
• Pascual MJ, Serrano MA, El-Mir MY, et al. Relationship between asymptomatic hypercholanaemia of pregnancy and progesterone metabolism. Clin Sci . 2002;102(5):587–593. doi: 10.1042/cs1020587.
   Web of Science ®Google Scholar
• Feng D, Yang XJ. A clinical dilemma: pregnancy with asymptomatic elevated total serum bile acid levels. J Obstet Gynaecol. 2014;34(5):444–445. doi: 10.3109/01443615.2014.912619.
   PubMedGoogle Scholar
• Feng D, He W. Asymptomatic elevated total serum bile acids representing an unusual form of intrahepatic cholestasis of pregnancy. Int J Gynaecol Obstet. 2016;134(3):343–344. doi: 10.1016/j.ijgo.2016.04.004.
   PubMed Web of Science ®Google Scholar
• He Y, Zhang X, Shao Y, et al. Recognition of asymptomatic hypercholanemia of pregnancy: different clinical features, fetal outcomes and bile acids metabolism from intrahepatic cholestasis of pregnancy. Biochim Biophys Acta Mol Basis Dis. 2022;1868(1):166269. doi: 10.1016/j.bbadis.2021.166269.
   PubMed Web of Science ®Google Scholar
• Girling J, Knight CL, Chappell L,. Intrahepatic cholestasis of pregnancy: green-top guideline no. 43 june 2022: green-top Guideline No. 43 June 2022. BJOG. 2022;129(13):e95–e114. doi: 10.1111/1471-0528.17206.
   PubMed Web of Science ®Google Scholar
• Lee RH, Greenberg M, Metz TD, et al. Society for maternal-fetal medicine consult series #53: intrahepatic cholestasis of pregnancy: replaces consult #13, april 2011.Am J Obstet Gynecol. 2021; 224(2): B2–B9. doi: 10.1016/j.ajog.2020.11.002.
   PubMed Web of Science ®Google Scholar
• Brouwers L, Koster MPH, Page-Christiaens GCML, et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol. 2015;212(1):100.e1–100.e7. doi: 10.1016/j.ajog.2014.07.026.
   PubMed Web of Science ®Google Scholar
• Huri M, Seravalli V, Lippi C, et al. Intrahepatic cholestasis of pregnancy - Time to redefine the reference range of total serum bile acids: a cross-sectional study. BJOG. 2022;129(11):1887–1896. doi: 10.1111/1471-0528.17174.
   PubMed Web of Science ®Google Scholar
• Mitchell AL, Ovadia C, Syngelaki A, et al. Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case-control and cohort study. BJOG. 2021;128(10):1635–1644. doi: 10.1111/1471-0528.16669.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Bell JL, Smith A, et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet. 2019;394(10201):849–860. doi: 10.1016/S0140-6736(19)31270-X.
   PubMed Web of Science ®Google Scholar
• Nivatpumin P, Lertbunnaphong T, Maneewan S, et al. Comparison of perioperative outcomes and anesthetic-related complications of morbidly obese and super-obese parturients delivering by cesarean section. Ann Med. 2023;55(1):1037–1046. doi: 10.1080/07853890.2023.2187877.
   PubMed Web of Science ®Google Scholar
• Cauldwell M, Mackie FL, Steer PJ, et al. Pregnancy outcomes in women with primary biliary cholangitis and primary sclerosing cholangitis: a retrospective cohort study. BJOG. 2020;127(7):876–884. doi: 10.1111/1471-0528.16119.
   PubMed Web of Science ®Google Scholar
• Yang Q, Zheng J, Chen W, et al. Association between preadmission metformin use and outcomes in intensive care unit patients with sepsis and type 2 diabetes: a cohort study. Front Med . 2021;8:640785. doi: 10.3389/fmed.2021.640785.
   Web of Science ®Google Scholar
• Vasavan T, Deepak S, Jayawardane IA, et al. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations. J Hepatol. 2021;74(5):1087–1096. doi: 10.1016/j.jhep.2020.11.038.
   PubMed Web of Science ®Google Scholar
• Fan HM, Mitchell AL, Williamson C. Endocrinology in pregnancy: metabolic impact of bile acids in gestation. Eur J Endocrinol. 2021;184(3):R69–R83. doi: 10.1530/EJE-20-1101.
   PubMedGoogle Scholar
• Li W, Shu S, Cheng L, et al. Fasting serum total bile acid level is associated with coronary artery disease, myocardial infarction and severity of coronary lesions. Atherosclerosis. 2020;292:193–200. doi: 10.1016/j.atherosclerosis.2019.11.026.
   PubMed Web of Science ®Google Scholar
• Wang L, Lu Z, Zhou X, et al. Effects of intrahepatic cholestasis of pregnancy on hepatic function, changes of inflammatory cytokines and fetal outcomes. Exp Ther Med. 2019;17(4):2979–2984. doi: 10.3892/etm.2019.7312.
   PubMed Web of Science ®Google Scholar
• Ray K. PITCHing ursodeoxycholic acid in intrahepatic cholestasis of pregnancy versus placebo. Nat Rev Gastroenterol Hepatol. 2019;16(10):582. doi: 10.1038/s41575-019-0201-3.
   Google Scholar
• Estiú MC, Frailuna MA, Otero C, et al. Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid. PLOS One. 2017;12(4):e176504. doi: 10.1371/journal.pone.0176504.
   PubMed Web of Science ®Google Scholar
• Hu YY, Liu JC, Xing AY. Oxidative stress markers in intrahepatic cholestasis of pregnancy: a prospective controlled study. Eur Rev Med Pharmacol Sci. 2015;19(17):3181–3186.
   PubMed Web of Science ®Google Scholar
• Tian Z, Yao N, Wu Y, et al. Association between plasma level of superoxide dismutase and survival of patients with acute-on-chronic liver failure. BMC Gastroenterol. 2022;22(1):50. doi: 10.1186/s12876-022-02126-y.
   PubMed Web of Science ®Google Scholar
• He Y, Wang F, Yao N, et al. Serum superoxide dismutase level is a potential biomarker of disease prognosis in patients with HEV-induced liver failure. BMC Gastroenterol. 2022;22(1):14. doi: 10.1186/s12876-022-02095-2.
   PubMed Web of Science ®Google Scholar
• Wang F, He Y, Yao N, et al. High levels of serum superoxide dismutase as a biomarker of intrahepatic cholestasis of pregnancy in patients with viral hepatitis B. BMC Pregnancy Childbirth. 2022;22(1):444. doi: 10.1186/s12884-022-04776-y.
   PubMed Web of Science ®Google Scholar
• Deng K, Liang J, Mu Y, et al. Preterm births in China between 2012 and 2018: an observational study of more than 9 million women. Lancet Glob Health. 2021;9(9):e1226–e1241. doi: 10.1016/S2214-109X(21)00298-9.
   PubMed Web of Science ®Google Scholar
• Mei Y, Lin Y, Luo D, et al. Perinatal outcomes in intrahepatic cholestasis of pregnancy with monochorionic diamniotic twin pregnancy. BMC Pregnancy Childbirth. 2018;18(1):291. doi: 10.1186/s12884-018-1913-z.
   PubMedGoogle Scholar
• Wikström Shemer E, Marschall HU, Ludvigsson JF, et al. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG. 2013;120(6):717–723. doi: 10.1111/1471-0528.12174.
   PubMed Web of Science ®Google Scholar
• Momany AM, Jasper E, Markon KE, et al. Latent class analysis to characterize neonatal risk for neurodevelopmental differences. J Child Psychol Psychiatry. 2022;64(1):100–109. doi: 10.1111/jcpp.13671.
   PubMed Web of Science ®Google Scholar